Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 11:2022:4225682.
doi: 10.1155/2022/4225682. eCollection 2022.

Effects of Gymnema inodorum Leaf Extract on the Alteration of Blood Coagulation Parameters and Platelet Count in Plasmodium berghei-Infected Mice

Affiliations

Effects of Gymnema inodorum Leaf Extract on the Alteration of Blood Coagulation Parameters and Platelet Count in Plasmodium berghei-Infected Mice

Kongsak Boonyapranai et al. J Parasitol Res. .

Abstract

Malaria remains highly prevalent and one of the major causes of morbidity and mortality in tropical and subtropical regions. Alteration of blood coagulation and platelets has played an important role and attributed to increased morbidity in malaria. Hence, this study was performed to investigate the efficacy of Gymnema inodorum leaf extract on Plasmodium berghei-induced alteration of blood coagulation parameters and platelet numbers in mice. Groups of ICR mice were inoculated with 1 × 107 parasitized red blood cells of P. berghei ANKA (PbANKA) and given orally by gavage with 100, 250, and 500 mg/kg of G. inodorum leaf extract (GIE). Chloroquine (10 mg/kg) was used as a positive control. Platelet count and blood coagulation parameters were measured. The results showed that PbANKA induced thrombocytopenia in mice as indicated by markedly decreased platelet count. Decreased platelet count had a negative correlation with the degree of parasitemia with R 2 value of 0.6668. Moreover, significantly (p < 0.05) shortened activated partial thromboplastin time was found in PbANKA-infected group, while prothrombin time and thrombin time were still normal. GIE gave significantly (p < 0.05) good results with respect to platelet count, compared with the results obtained from positive and healthy controls. Additionally, GIE reversed the alteration of blood coagulation parameters when compared to untreated mice. The highest efficacy of GIE was observed at a dose of 500 mg/kg. It was concluded that GIE exerted a protective effect on thrombocytopenia and altered blood coagulation parameters induced by PbANKA infection in mice. This plant may be a future candidate for alternative antimalarial development.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that there are no conflicts of interest regarding the publication of this manuscript.

Figures

Figure 1
Figure 1
PbANKA-induced thrombocytopenia. ICR mice were infected with 1 × 107 parasitized RBC of PbANKA by intraperitoneal injection. (a) Parasitemia and platelet count were monitored. (b) Correlation between parasitemia and platelet count was also observed. Results were presented as mean ± SEM.
Figure 2
Figure 2
Antithrombocytopenia effect of GIE on PbANKA-infected mice. Groups of ICR mice were inoculated with 1 × 107 parasitized RBC by intraperitoneal injection. GIE (100, 250, and 500 mg/kg) was given orally by gavage for 4 consecutive days. Platelet count was measured using an automated analyzer. The results were presented as mean ± SEM. H: healthy; UN: untreated; GI100, GI250, and GI500: GIE treatment at doses of 100, 250, and 500 mg/kg; CQ: 10 mg/kg of chloroquine. ∗∗p < 0.01 and ∗∗∗p < 0.001 compared to H. ##p < 0.01 and ###p < 0.001 compared to UN.
Figure 3
Figure 3
Effect of GIE on blood coagulation parameters in PbANKA-infected mice. Groups of ICR mice were inoculated with 1 × 107 parasitized RBC by intraperitoneal injection. GIE (100, 250, and 500 mg/kg) was given orally by gavage for 4 consecutive days. Blood coagulation parameters, including (a) PT, (b) APTT, and (c) TT, were measured using an automated analyzer. The results were presented as mean ± SEM. H: healthy; UN: untreated; GI100, GI250, and GI500: GIE treatment at doses of 100, 250, and 500 mg/kg; CQ: 10 mg/kg of chloroquine. ∗∗p < 0.01 compared to H. #p < 0.05 compared to UN.

Similar articles

Cited by

References

    1. Sato S. Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology. Journal of Physiological Anthropology . 2021;40(1):p. 1. doi: 10.1186/s40101-020-00251-9. - DOI - PMC - PubMed
    1. WHO. World Health Organization, World Malaria Report. 2020, https://www.who.int/publications/i/item/9789240015791.
    1. Fairhurst R. M., Dondorp A. M. Artemisinin-resistant Plasmodium falciparum malaria. Microbiology Spectrum . 2016;4(3) doi: 10.1128/microbiolspec.EI10-0013-2016. - DOI - PMC - PubMed
    1. Buffet P. A., Safeukui I., Deplaine G., et al. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood . 2011;117(2):381–392. doi: 10.1182/blood-2010-04-202911. - DOI - PMC - PubMed
    1. Kotlowski A. An overview of pathophysiological theories in Plasmodium falciparum cerebral malaria with the special reference to the role of cytokines. Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia . 1993;44-45(1-4):103–108. - PubMed

LinkOut - more resources